List of works - Allison C Rosenthal

A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma.

scientific article published on 25 September 2015

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

scientific article published on 23 February 2017

A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma

scientific article published on 10 January 2018

Carfilzomib and the cardiorenal system in myeloma: an endothelial effect?

scientific article published on 15 January 2016

Classical Hodgkin lymphoma masquerading as chronic recurrent multifocal osteomyelitis: a case report

scientific article published on 18 February 2017

Extramedullary Cardiac Multiple Myeloma-A Case Report and Contemporary Review of the Literature.

scientific article published on 18 February 2016

High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma.

scientific article

Janus kinase inhibitors for the treatment of myeloproliferative neoplasms.

scientific article published on 25 April 2014

Multidisciplinary Management of Adolescent and Young Adult Patients with Hodgkin Lymphoma

scientific article published in 2021

Pitfall of F-FDG PET/CT in Characterization of Relapsed Multisystem Lymphomatoid Granulomatosis

scientific article published on 08 June 2018

Predictors and management of relapse to Axicabtagene Ciloleucel in patients with aggressive B-cell lymphoma

scientific article published in 2021

Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma

scientific article published on 03 June 2018

Rituximab maintenance therapy for mantle cell lymphoma: A systematic review and meta-analysis

scientific article published on 03 September 2018

Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.